STop and Restart Acalabrutinib In fRail Patients With Previously Untreated Chronic Lymphocytic Leukemia

NCT04963946 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Untreated Chronic Lymphocytic Leukemia

Interventions

DRUG: Stop ACA
DRUG: ACA Continuation

Sponsor

French Innovative Leukemia Organisation